The search for safer and more effective options to treat multiple sclerosis (MS) is an active focus of research around the globe. To date, about half a dozen therapies are FDA approved—and only for certain forms of the complex disease. The following advances were reported in late 2008: •Major pharmaceutical company Novartis released promising results ...
More